Ann: Low pH Field Demonstration Update, page-165

First 165 Last

Share
Profile

Follow
tutes

3,326 Posts.

691

25/04/21

09:34

Post #: 52704965
Share

Originally posted by Jaat308 ↑

The first row position pen is in !
( having noticed that there is a lot of new blood in the space ) and don't really understand what it takes to Go into production
one poster in particular I read the company is a u explorer with nothing ? and he stated that the ceo said they will go into production when spot get to $50 ........well we all know that is fairy floss That could take up to 10 years if he gets that far and lots and lots of $. And if he finds and developed a resource...... then there are the miners with a developed resource with all studies in place feasibility opex capex and approvals etc ? Just waiting for the spot to rise to x dollars and TRY to secure contracts to finance there biggest expense infrastructure about $300m plus and around 3 years to complete ......bannerman resources changed his plans to construct a mine that was capable to produce 7mlb per year cost was about under $ 800m usd and about 5 years to construct The funding needed was to much and was going to take to long time is of essence !!!!!!!! so now the project is etango 8 which scaled down to 3.5mlb production mine. So every developer wants to get into production ASAP. But we know there years away.......
Thats where the producers shine they are in the front row and will be first off the mark !
On the asx there are only 4 , paladin. Lotus....boss.....peninsula..
We all know pen uranium project the prime position in U S a country with the biggest uranium consumption with growth and government backing ... the chemistry as stated in the last interview the ceo said when the spot price moves in pen is ready to go into production as is where's is. ( only a few miners in the world can do that ) !,

Expand

can't remember the exact stats or where i read it, but the majority of explorers don't even make it to production...

something like 8 or 9 out of 10 companies don't even get to the production stage

PEN Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

OJC

SPC to merge with Original Juice Co and Nature One Dairy

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 41 more messages in this thread...

First 165 Last

Add PEN (ASX) to my watchlist

(20min delay)
Last 9.6¢		Change 0.000(0.00%)		Mkt cap ! $305.9M

Open	High	Low	Value	Volume
9.6¢	10.5¢	9.1¢	$2.766M	27.91M

Buyers (Bids)

No.	Vol.	Price($)
2	317999	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	180000	1

View Market Depth

No.	Vol.	Price($)
2	317999	0.096
2	400000	0.095
2	110989	0.091
8	1188742	0.090
3	71235	0.089

Price($)	Vol.	No.
0.098	180000	1
0.099	300000	1
0.100	293948	4
0.105	4452526	36
0.110	4053261	39

Last trade - 16.10pm 02/10/2024 (20 minute delay)

PEN (ASX) Chart

Ann: Low pH Field Demonstration Update, page-165

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Low pH Field Demonstration Update, page-165

Top Stories

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News